小鼠 (Mouse) 晚期糖基化终末产物 (AGEs)-分析方法-资讯-生物在线

小鼠 (Mouse) 晚期糖基化终末产物 (AGEs)

作者:上海逸峰生物科技有限公司 2011-10-09T00:00 (访问量:1900)

Goat anti-Mouse Advanced glyosylation end prodrcts

                                                                Collect Sample – serum or blood plasma        

Storage: 2 - 8 °C                                       Package size: 96 determinations  

PRINCIPLE OF THE METHOD

The AGEs kit is a solid phase phase sandwich enzyme linked immuno sorbent assay(ELISA). Samples , including standards of  known AGEs concentrations and unknowns are pipetted into these wells. During the first incubation, the AGEs antigen and a biotinylated monoclonal antibody specific for AGEs are simultaneously incubated. After washing, the enzyme(streptavidin-peroxydase)is added. After incubation and washing to remove all the unbound enzyme, a substrate solution which is acting on the bound enzyme is added to induce a coloured reaction product. The intensity of this coloured product is directly proportional to the concentration of AGEs present in the samples.

REAGENTS PROVIDED AND RECONSTTTUTION

REAGENTSStore at 2-8

1×96 WELLS

0.5×96 WELLS

RECONSTTTUTION

96/48-wells microtiter plates

1

0.5

Ready-to-use

Plastiv cover

2

1

Ready-to-use

Standard: 400ng/ml

1Vials  (0.6ml)

0.5Vials  (0.3ml)

See reagents preparation on page 3

Blank control

1Vials  (1.0ml)

1Vials   (0.5ml)

Ready-to-use

Standard Diluent

1Vials  (5ml)

1Vials   (2.5ml)

Ready-to-use

Biotinylated anti-AGEs

1Vials  (6ml)

1Vials   (3.0ml)

Ready-to-use

Streptavidin-HRP

1Vials  (10ml)

1Vials   (5.0ml)

Ready-to-use

Washing Buffer

1Vials  (20ml)

1Vials   (10ml)

50× concentrate

Substrate  A

1Vials  (6.0ml)

1Vials   (3.0ml)

Ready-to-use

Substrate  B

1Vials 6.0ml)

1Vials   (3.0ml)

Ready-to-use

Stopping Solution

1Vials  (6.0ml)

1Vials   (3.0ml)

Ready-to-use

Sample Diluent

1Vials  (12ml)

1Vials   (6.0ml)

Ready-to-use

MATERIAL REQUIRED BUT NOT PROVIDED

l       Distilled water

l       Pipettes:10ul50ul100ul200ul1000ul

l       Vortex mixer and magnetic stirrer.

SAFETY

l       For research use only

l       Avoid any skin contact with H2SO4 and TMB. In case of contact, wash thoroughly water.

l       Do not eat, drink, smoke or apply cosmetics where kit reagents are used.

l       Do not pipette by mouth.

PROCEDURAL NOTES/LAB.QUALITY CONTROL

l       When not in use, kit components should be stored refrigerated or frozen as indicated on vials or bottles. All reagents should be warmed to room temperature before use. Lyophilized standards should be discarded after use.

l       Once the desired number of strips has been removed, immediately reseal the bag to protect the remaining strips from edterioration.

l       Cover or cap all reagents when not in use.

l       Do not mis or interchange reagents between different lots.

l       Do not use reagents beyond the expiration date of the kit .

l       Use a clean disposable plastic pipette tip for each reagent, standard, or specimen addition in order to avoid cross-contamination, for the dispensing of H2SO4 and substrate solution, avoid pipettes with metal parts.

l       Use a clean plastic container to prepare the washing solution.

l       Thoroughly mix the reagents and samples before use by agitation or swirling.

l       All residual washing liquid must be drained from the wells by efficient aspiration or by decantation followed by tapping the plate forcefully on absorbent paper. Never insert absorbent paper directly into the wells.

l       The TMB solution is light sensitive. Avoid prolonged exposure to light, also, avoid contact of the TMB solution with metal to prevent colour development. Warning TMB is toxic avoid direct contact with hands. Dispose off properly. If a dark blue colour develops within a few minutes after preparation, this indicates that the TMB solution has been contaminated and must be discarede. Read absorbances within 1 hour after completion of the assay.

l       When pipetting reagents, maintain a consistent order of addition from well-to-well. This will ensure equal incubation times for all wells.

l       Respect incubation times described in the assay procedure.

SPECIMEN COLLECTION\ PROCESSING AND STORAGE

l       Serum---Avoid any inintentional stimulation of the cells by the procedure. Use pyrogen\endotoxin free collecting tubes. Serum should be removed rapidly and carefully from the red cells after clothing. For that, after clothing, centrifuge at approximately 1000×g for 10 min and remove serum.

l       Plasma---EDTA\ citrate and heparin plasma can be assayed. Spin samples at 1000×g for 30 min remove particulates. Harvest plasma.

l       Cell culture supernatants---Remove particulates and aggregates by spinning at approximately 1000×g for 10 min.

l       Storage---If not analyzed shortly after collection, samples should be aliquoted(250-500ul) to avoid freeze-thaw cycles and stored frozen at -70. Avoid multiple freeze-thaw cycles of frozen specimens. When possible, avoid use of badly hemolyzed or lipemic sera. If large amounts of particles are present, this should be removed prior to assay by centrifugation or filtration.

l       Recommendation---Do not thaw by heating at 37 or 56. Thaw at room temperature and make sure that sample is completely thawed and homogenous before assaying.

PREPARATION OF REAGENTS

l       Standards: Standard have to be reconstituled with the volume of standard buffer diluent indicated on the vial. This reconstitution produces a stock solution of 400ng/ml AGEs. Allow standard to stand for 5

l       minutes with gentle swirling prior to making dilutions. Serial dilutions of standard must be made before each assys and cannot be stored.

400 ng/ml

6  Standard

Original density 50ul

200 ng/ml

5  Standard

100ul  6 Standard  +100ul diludent

100 ng/ml

4  Standard

100ul  5 Standard  +100ul diludent

50 ng/ml

3  Standard

100ul  4 Standard  +100ul diludent

25 ng/ml

2  Standard

100ul  3 Standard  +100ul diludent

12.5 ng/ml

1  Standard

100ul  2 Standard  +100ul diludent

0 ng/ml

Blank Control

50ul

l       Washing buffer 50×concentrate:  Dilute 50 times in distilled water.

ASSAY METHOD

l       Before use, mix all reagents thoroughly without making foam.

l       Determine the number of microwell strips required to test the desired number of samples,plus appropriate number of wells needed for running blanks standards. Each sample, standard and blank should be assayed in duplicate. Remove sufficient microwell strips from the pouch.

l       Add 50ul of standard diluent to standard wells B1,B2,  C1,C2,  D1,D2,  E1, E2,  F1,F2. Reconstitute standard vial with the appropriate volume as described in the chapter reagents preparation. Preparation. Pipet 100ul of standard into wells A1 and A2 (see plate scheme below). Transfer 50ul from A1 and A2 to B1 and B2 wells. Mix the contents by repeated aspirations and ejections. Take care not to scratch the inner surface of microwells. Repat this procedure from the wells B1,B2 to wells C1,C2 and from wells C1,C2 to D1,D2 and so on creating two parallel rows of AGEs standard dilutions rangingAdd 50ul of standard diluent to the bland wells.

l       Dilute samples 1:1 distribing 50ul of sample into 50ul of dilluent ,Add 50ul of diluted sample to wells..

l       Add 50ul of diluted biotinylated anti-AGEs to all wells.

l       Cover with a plate vover and incubate for 1 hour at 37.

l       Remove the cover and wash the plate as follows: ⑴ aspirate the liquid from each well, ⑵ dispensse 0.3ml of washing solution into each well. ⑶ Aspirate again the contet of each well after 0.5 minute. ⑷ Repeat steps and three times.

l       Distribute 80ul of streptavidin-HRP solution to all wells, including blank wells.

上海逸峰生物科技有限公司 商家主页

地 址: 上海市杨浦区政悦路88弄15号

联系人: 陈锋

电 话: 86-021-31665985

传 真: 86-021-51862175

Email:fd6218@sina.com

相关咨询

人乙型肝炎病毒X蛋白相互作用蛋白(HBXIP)酶联免疫分析 (2011-08-02T00:00 浏览数:2568)

中科院杰青Nature发表最新研究成果 (2011-07-29T00:00 浏览数:2406)

华裔博士6,7月连发Nature、Science文章 (2011-07-21T00:00 浏览数:2737)

物理学家Science发表令人震惊的生物学成果 (2011-07-18T00:00 浏览数:1226)

**美女科学家Nature文章解析miRNA (2011-07-15T00:00 浏览数:1868)

2011候选院士最新Nature子刊文章 (2011-07-14T00:00 浏览数:1569)

复旦大学教授PNAS文章聚焦糖尿病 (2011-07-13T00:00 浏览数:1581)

Nature新闻:拟人小鼠用于药物开发 (2011-07-12T00:00 浏览数:1710)

首都医科大学发Nature综述文章 (2011-07-08T00:00 浏览数:1391)

首都医科大学发Nature综述文章 (2011-07-07T00:00 浏览数:1526)

ADVERTISEMENT